DEP-lutetium (Starpharma Holdings)

N/A

Report date: 2025/01/19 10:54:23

Base Information

Drug NameDEP-lutetium (Starpharma Holdings)
Drug Alias NameDEP-lutetium 177
ClassificationRadiation-emitting productsBiologics
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsProstatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia and New Zealand
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesStarpharma Pty Ltd
China Registration ClassN/A

Develop Information

Active CompaniesStarpharma Pty Ltd
Inactive CompaniesN/A
Active IndicationsProstatic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A